CHMP start for aclidinium's adventures in COPD land (and what Almirall did next)
This article was originally published in Scrip
Executive Summary
Almirall's long-acting inhaled antimuscarinic agent (LAMA) aclidinium bromide has been granted a positive EU CHMP opinion for the treatment of chronic obstructive pulmonary disease (COPD).